J Korean Dent Assoc > Volume 49(7); 2011 > Article
Journal of Korean Dental Association 2011;49(7):389-397.
DOI: https://doi.org/10.22974/jkda.2011.49.7.003    Published online July 31, 2011.
Bisphosphonate를 복용하는 환자에게 임프란트 치료시 고려사항
박원서1, 정원윤2, 김형준3, 김기덕4
1연세대학교 치과대학 통합진료학과
2연세대학교 치과대학 구강생물학교실
3연세대학교 치과대학 구강악안면외과학교실
4연세대학교 치과대학 통합진료학과
Considerations during dental implant treatment for patients under bisphosphonate therapy
Won-Se Park1, Won-Yoon Chung2, Hyung-Jun Kim3, Kee-Deog Kim4
1Department of advanced general dentistry, College of dentistry, Yonsei University
2Department of oral biology, College of dentistry, Yonsei University
3Department of oral and maxillofacial sugery, College of dentistry, Yonsei University
4Department of advanced general dentistry, College of dentistry, Yonsei University
Abstract
Bisphosphonate inhibits the function of osteoclast, so they are widely used for multiple myeloma, Paget's disease, metastatic malignant bone disease, and severe osteoporosis. This drug is very effective for preventing severe complication of osteoporosis, some unpredictable complication occurred such as esophageal malignancy, atypical fracture of femur, and osteonecrosis of the jaw. Bisphosphonate related osteonecrosis of the jaw (BRONJ) is closely related with invasive, open bone surgery like tooth extraction. BRONJ associated with dental implant is rare, however, as the use of bisphosphonate increase, BRONJ cases with dental implant are increasing. In this article, we will describe the considerations during dental implant treatment for patient under bisphosphonate therapy.
Key Words: Bisphosphonate;implant;dental considerations;


Editorial Office
Korean Dental Association, 257 Gwangnaru-ro, Seongdong-gu, Seoul 04802, Korea
Tel: +82-2-2024-9100   Fax: +82-2-468-4655/58   

Copyright © 2025 by Korean Dental Association.

Developed in M2PI